Shenzhen Oriental Fortune Capital Co Ltd.

Streamlined workflow, robust assay results, economical in both labor and cost

Pillar Biosciences’ novel SLIMamp NGS target enrichment provides a simple and efficient workflow where PCR amplification of overlapping products occurs with a minimum of sample input and in a single well. This easy-to-use assay biochemistry is coupled with Pillar’s proprietary PiVAT™ bioinformatics analysis pipeline, producing highly sensitive and reproducible results. With a minimal amount of hands-on time and a sample-to-sequencer timeframe of less than eight hours, Pillar Biosciences’ ONCO/Reveal products save you both time and money.

Streamlined Workflow

  • Single-well amplification
  • DNA to Sequencer in <8 hours
  • Germline, Somatic and Liquid Biopsy Cancer Panels

Robust Technology

  • Generate results with as little as 2.5 ng FFPE DNA sample input (solid tumor assays) or 20 ng circulating tumor DNA (liquid biopsy assays)
  • Even sequencing coverage of target regions
  • Custom panels available